Intensive lifestyle intervention improves health-related quality of life in patients with obesity

This randomized controlled trial evaluated the impact of a 24-month intensive lifestyle intervention on health-related quality of life in patients with obesity. The study population consisted of 803 patients recruited from eighteen primary care clinics. Participants were randomized to receive either the intensive lifestyle intervention or usual care. The intervention duration was 24.0 months. The comparator was standard usual care provided within the clinic setting. The primary outcome measure was health-related quality of life. Secondary outcomes included weight-related quality of life and generic health-related quality of life.

The primary analysis examined the association between weight loss categories and changes in weight-related quality of life. Patients achieving less than 5 percent weight loss showed a 7.4 point improvement in weight-related quality of life. The 95 percent confidence interval for this group was 5.1 to 9.7. Patients achieving 5 percent to less than 10 percent weight loss showed a 15.0 point improvement. The 95 percent confidence interval for this group was 11.4 to 18.5. Patients achieving 10 percent or greater weight loss showed an 18.9 point improvement. The 95 percent confidence interval for this group was 15.4 to 22.4. These results indicate a graded positive association between the magnitude of weight loss and improvements in weight-related quality of life.

Analysis of generic health-related quality of life domains also revealed a positive association with weight loss. Greater weight loss was related to greater improvements in most generic health-related quality of life domains. Specific effect sizes and confidence intervals for these generic domains were not reported in the study data. The study also investigated whether improvements in weight-related quality of life differed by race. Black patients experienced less improvement in weight-related quality of life compared to other racial groups. Specific effect sizes and confidence intervals for this racial difference were not reported.

The study assessed whether changes in generic health-related quality of life differed by race or sex. Results indicated that changes did not differ by race or sex for the generic health-related quality of measure. Similarly, improvements in weight-related quality of life did not differ by sex. Specific effect sizes and confidence intervals for these sex and race comparisons were not reported. The study did not report data on adverse events, serious adverse events, discontinuations, or overall tolerability. Consequently, safety findings are not reported in the available data.

A key methodological limitation identified was the observation of race differences in changes in weight-related quality of life. This finding highlights the need for precision medicine approaches to weight loss. The study examined the association between weight loss and changes in health-related quality of life. The randomized controlled trial design supports causal inference regarding the intervention effect. However, the lack of reported safety data limits the ability to assess the tolerability of the intensive lifestyle intervention. The study did not report funding sources or potential conflicts of interest.

These results suggest that while weight loss generally improves quality of life, the magnitude of benefit varies by race. Clinicians should recognize that Black patients may experience less improvement in weight-related quality of life compared to other groups. Questions remain unanswered regarding the mechanisms driving these racial disparities. Future research should investigate strategies to optimize quality of life outcomes across all racial groups. The absence of safety data means clinicians cannot yet assess the risk profile of this specific intervention protocol.

In summary, this trial demonstrates that a 24-month intensive lifestyle intervention improves health-related quality of life in patients with obesity. The improvement is graded by the amount of weight lost. However, racial disparities in weight-related quality of life improvements were observed. Clinicians should consider these findings when counseling patients on realistic expectations for quality of life gains. The lack of safety reporting is a significant gap in the current evidence base.